Swiss pharmaceutical giant Roche said Friday it had developed an antibody test that it hopes to roll out in May to detect people previously infected with COVID-19, even those who displayed no symptoms.
/https://s1.mihaaru.com/photos/2020/02/12/267600_3_097e8fd10870b869066ad5b2e030148febf25d5e_large.jpg)
Doctor Paul McKay, who is working on an vaccine for the 2019-nCoV strain of the novel coronavirus, Covid-19,, poses for a photograph with bacteria containing the coronavirus, Covid-19, DNA, at Imperial College School of Medicine (ICSM) in London on February 10, 2020. - A team of UK scientists believe they are one of the first to start animal testing of a vaccine for the new coronavirus that has killed more than 1,000 people and spread around the world. (Photo by Tolga AKMEN / AFP) /
2020-04-17 14:15:03
Swiss pharmaceutical giant Roche said Friday it had developed an antibody test that it hopes to roll out in May to detect people previously infected with COVID-19, even those who displayed no symptoms.
Roche said in a statement that it had developed the Elecsys Anti-SARS-CoV-2 immunoassay, which using a blood sample can detect antibodies to determine the body's immune reaction to the novel coronavirus that causes COVID-19.
Copyright © 2025 The Edition
/https://cdn.mihaaru.com/photos/2025/03/03/412239_3_0d44335ad3c46bcc013565bc8f2b060cc771eb05_large.jpg)
/https://s1.mihaaru.com/photos/2024/11/18/405822_3_42991b287152e728fb9dc1a34b047616b3c170b2_large.jpg)
/https://s2.mihaaru.com/photos/2025/02/22/411540_3_4a48676775adcce55fa65b35db06d54c556c2d45_large.jpg)
/https://s3.mihaaru.com/photos/2025/01/20/409609_3_8619638b962d13f7368c9bfe329a353eeeb47616_large.jpg)